Business
Quantum-Si Announces New Manuscript Demonstrating the Value of Single-molecule Protein Sequencing to Aid in Identifying New Cancer Treatment Strategies
BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein
About this update from Quantum-si Incorporated
[{"type":"text","content":" BRANFORD, Conn.--(BUSINESS WIRE)--\nQuantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced a new manuscript available via pre-print on bioRxiv from researchers out of the University of British Columbia and the B.C. Cancer Research Institute.\n\n\nIn the pre-print titled “Heterologous expression of the human cohesin complex in Saccharomyces cerevisiae results in a dominant-negative phenotype”, the researchers expressed key human chromosome‑organizing proteins (called cohesins) in yeast cells. They hypothesized that the human cohesins were forming complexes and disrupting the activity of endogenous yeast cohesins. This matters for cancer drug development because problems with cohesin can drive genome instability in tumors, pointing to new ways to target cancer cells. Quantum-Si’s single‑molecule protein sequencing was critical to the study because it provided direct, unbiased data demonstrating that human and yeast cohesin proteins physically assemble into the same complexes—something conventional antibodies and assays could not fully resolve.\n\n\n“We are excited to see the first manuscript published by international researchers,” said Jeff Hawkins, President and Chief Executive Officer of Quantum-Si. “In this study, single‑molecule protein sequencing enabled the researchers at University of British Columbia and B.C. Cancer Research Institute to directly identify hybrid cohesin complexes, demonstrating the value of our technology as a foundational tool for mechanistic biology research and therapeutic discovery.”\n\n\nA link to the bioRxiv pre-print can be found here.\n\n\nAbout Quantum-Si Incorporated\n\n\nQuantum-Si is transforming proteomics with a benchtop platform that brings single-molecule protein analysis to every lab, everywhere. The Company’s platform enables real-time kinetic-based detection and allows researchers to move beyond traditional, multistep workflows and directly access dynamic, functional protein insights with unparalleled resolution. By making protein analysis simpler, faster, and more informative, Quantum-Si is accelerating proteomic discoveries to improve the way we live. Learn more at quantum-si.com or follow us on LinkedIn or X.\n\n\nForward Looking Statements\n\n\nThis pr...